Detalhe da pesquisa
1.
Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agents.
J Med Chem
; 50(4): 685-95, 2007 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-17243659
2.
Structure-based design of potent retinoid X receptor alpha agonists.
J Med Chem
; 47(8): 2010-29, 2004 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-15056000
3.
Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
Biochemistry
; 42(31): 9278-87, 2003 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-12899614
4.
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.
Bioorg Med Chem Lett
; 13(9): 1517-21, 2003 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-12699745
5.
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
Nature
; 415(6873): 813-7, 2002 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-11845213
6.
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.
Cell
; 110(1): 93-105, 2002 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-12151000